Morgans retains its Add rating and $2.48 target for HealthCo Healthcare & Wellness REIT, following 1H results that revealed strengthening portfolio metrics since the IPO.

FY22 guidance was reiterated and the broker believes the balance sheet provides future scope for acquisitions and development opportunities for the existing pipeline.

A distribution of 3cpu was declared for the period since listing to December, to be paid on 25 February.

Sector: Real Estate.

Target price is $2.48.Current Price is $2.09. Difference: $0.39 - (brackets indicate current price is over target). If HCW meets the Morgans target it will return approximately 16% (excluding dividends, fees and charges - negative figures indicate an expected loss).

© 2022 Acquisdata Pty Ltd., source FN Arena